nodes	percent_of_prediction	percent_of_DWPC	metapath
Chenodeoxycholic acid—CYP3A4—Everolimus—kidney cancer	0.102	0.293	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Temsirolimus—kidney cancer	0.069	0.198	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Pazopanib—kidney cancer	0.0362	0.104	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Erlotinib—kidney cancer	0.0259	0.0741	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Paclitaxel—kidney cancer	0.0237	0.0678	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Sorafenib—kidney cancer	0.021	0.0603	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Vinblastine—kidney cancer	0.0208	0.0595	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Vincristine—kidney cancer	0.0204	0.0585	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Sunitinib—kidney cancer	0.017	0.0488	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Doxorubicin—kidney cancer	0.0128	0.0366	CbGbCtD
Chenodeoxycholic acid—NR1H4—nephron tubule—kidney cancer	0.00911	0.111	CbGeAlD
Chenodeoxycholic acid—NR1H4—renal system—kidney cancer	0.00828	0.101	CbGeAlD
Chenodeoxycholic acid—NR1H4—kidney—kidney cancer	0.008	0.0976	CbGeAlD
Chenodeoxycholic acid—NR1H4—cortex of kidney—kidney cancer	0.00779	0.095	CbGeAlD
Chenodeoxycholic acid—CYP27A1—nephron tubule—kidney cancer	0.00663	0.0808	CbGeAlD
Chenodeoxycholic acid—CYP27A1—renal system—kidney cancer	0.00602	0.0735	CbGeAlD
Chenodeoxycholic acid—CYP3A4—urine—kidney cancer	0.00594	0.0724	CbGeAlD
Chenodeoxycholic acid—CYP27A1—kidney—kidney cancer	0.00582	0.071	CbGeAlD
Chenodeoxycholic acid—CYP27A1—cortex of kidney—kidney cancer	0.00567	0.0692	CbGeAlD
Chenodeoxycholic acid—CYP27A1—cardiac atrium—kidney cancer	0.0054	0.0658	CbGeAlD
Chenodeoxycholic acid—UGT2B7—renal system—kidney cancer	0.00533	0.065	CbGeAlD
Chenodeoxycholic acid—UGT2B7—kidney—kidney cancer	0.00516	0.0629	CbGeAlD
Chenodeoxycholic acid—CYP3A4—renal system—kidney cancer	0.00145	0.0177	CbGeAlD
Chenodeoxycholic acid—CYP3A4—kidney—kidney cancer	0.00141	0.0171	CbGeAlD
Chenodeoxycholic acid—UGT2B7—Phase II conjugation—GSTT1—kidney cancer	0.000669	0.00674	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—ALDH1A1—kidney cancer	0.000666	0.00671	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	0.000656	0.00662	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000651	0.00657	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—NRF2 pathway—KEAP1—kidney cancer	0.000636	0.00641	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Biological oxidations—GSTT1—kidney cancer	0.000628	0.00633	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Biological oxidations—GSTP1—kidney cancer	0.000595	0.006	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Biological oxidations—PTGS1—kidney cancer	0.000588	0.00593	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metapathway biotransformation—GSTP1—kidney cancer	0.000587	0.00592	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Irinotecan Pathway—BCHE—kidney cancer	0.000582	0.00587	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—kidney cancer	0.000575	0.0058	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Biological oxidations—GSTM1—kidney cancer	0.000547	0.00552	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—PPARA activates gene expression—CYP1A1—kidney cancer	0.000542	0.00547	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metapathway biotransformation—GSTM1—kidney cancer	0.00054	0.00544	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.000532	0.00536	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP1A1—kidney cancer	0.00053	0.00535	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.000519	0.00523	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Biological oxidations—CYP1A1—kidney cancer	0.000519	0.00523	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metapathway biotransformation—CYP1A1—kidney cancer	0.000512	0.00516	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Phase II conjugation—GSTP1—kidney cancer	0.000464	0.00467	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—ACY1—kidney cancer	0.000456	0.0046	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Tryptophan metabolism—ALDH1A1—kidney cancer	0.000439	0.00443	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Biological oxidations—GSTP1—kidney cancer	0.000435	0.00439	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—HARS—kidney cancer	0.000429	0.00432	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Phase II conjugation—GSTM1—kidney cancer	0.000426	0.0043	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Biological oxidations—GSTM1—kidney cancer	0.0004	0.00403	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—GSTT1—kidney cancer	0.000391	0.00395	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	0.000389	0.00392	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PDHB—kidney cancer	0.000388	0.00391	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Biological oxidations—POMC—kidney cancer	0.000387	0.0039	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—NRF2 pathway—SLC5A5—kidney cancer	0.000384	0.00387	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Biological oxidations—CYP1A1—kidney cancer	0.000379	0.00382	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—kidney cancer	0.000375	0.00379	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000374	0.00377	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000374	0.00377	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000374	0.00377	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—NRF2 pathway—SLC2A1—kidney cancer	0.000371	0.00374	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—PTGS1—kidney cancer	0.000367	0.0037	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—kidney cancer	0.000366	0.00369	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—CCBL1—kidney cancer	0.000365	0.00368	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—EIF5B—kidney cancer	0.000365	0.00368	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—kidney cancer	0.000363	0.00366	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Estrogen metabolism—GSTM1—kidney cancer	0.000348	0.00351	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—NRF2 pathway—EGR1—kidney cancer	0.000344	0.00347	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—ACY1—kidney cancer	0.000333	0.00336	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Estrogen metabolism—CYP1A1—kidney cancer	0.00033	0.00333	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	0.00033	0.00333	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PPAT—kidney cancer	0.000316	0.00319	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—GLIPR1—kidney cancer	0.000316	0.00319	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Irinotecan Pathway—APC—kidney cancer	0.000316	0.00319	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	0.000312	0.00315	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—NRF2 pathway—GSTP1—kidney cancer	0.000309	0.00312	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	0.000309	0.00312	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Xenobiotics—CYP1A1—kidney cancer	0.000303	0.00306	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—FH—kidney cancer	0.000294	0.00296	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—APRT—kidney cancer	0.000294	0.00296	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Tamoxifen metabolism—CYP1A1—kidney cancer	0.000292	0.00294	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	0.000288	0.0029	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	0.000287	0.0029	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	0.000284	0.00287	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—NRF2 pathway—GSTM1—kidney cancer	0.000284	0.00286	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PDHB—kidney cancer	0.000283	0.00286	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Biological oxidations—POMC—kidney cancer	0.000283	0.00285	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—ACY1—kidney cancer	0.000279	0.00281	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—GPC3—kidney cancer	0.000276	0.00279	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—GSTP1—kidney cancer	0.000271	0.00273	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—CA2—kidney cancer	0.000269	0.00271	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metapathway biotransformation—GSTP1—kidney cancer	0.000267	0.0027	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—CCBL1—kidney cancer	0.000267	0.00269	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—ALAD—kidney cancer	0.000262	0.00264	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—ST3GAL2—kidney cancer	0.000256	0.00258	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—ALDH1A1—kidney cancer	0.00025	0.00252	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—GSTM1—kidney cancer	0.000249	0.00251	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metapathway biotransformation—GSTM1—kidney cancer	0.000246	0.00248	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	0.000241	0.00243	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—SLC5A3—kidney cancer	0.00024	0.00242	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PGK1—kidney cancer	0.00024	0.00242	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—JUNB—kidney cancer	0.000237	0.00239	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—CYP1A1—kidney cancer	0.000236	0.00238	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—LDHB—kidney cancer	0.000235	0.00237	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—EEF2—kidney cancer	0.000235	0.00237	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metapathway biotransformation—CYP1A1—kidney cancer	0.000233	0.00235	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PPAT—kidney cancer	0.000231	0.00233	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—GLIPR1—kidney cancer	0.000231	0.00233	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	0.000228	0.0023	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	0.000226	0.00228	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	0.000226	0.00228	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—TET2—kidney cancer	0.000225	0.00227	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	0.000216	0.00217	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—FH—kidney cancer	0.000215	0.00217	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—APRT—kidney cancer	0.000215	0.00217	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	0.00021	0.00212	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—ACY1—kidney cancer	0.000208	0.0021	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—TCEB2—kidney cancer	0.000206	0.00208	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—TCEB1—kidney cancer	0.000206	0.00208	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—CA9—kidney cancer	0.000204	0.00205	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—GPC3—kidney cancer	0.000202	0.00204	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	0.000199	0.00201	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000197	0.00199	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—CA2—kidney cancer	0.000197	0.00198	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—CDKN2B—kidney cancer	0.000193	0.00194	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—ALAD—kidney cancer	0.000191	0.00193	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.00019	0.00192	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—ST3GAL2—kidney cancer	0.000187	0.00188	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—ALDH1A1—kidney cancer	0.000183	0.00184	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PDHB—kidney cancer	0.000177	0.00178	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—POMC—kidney cancer	0.000176	0.00178	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—SLC5A3—kidney cancer	0.000175	0.00177	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PGK1—kidney cancer	0.000175	0.00177	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—CRABP1—kidney cancer	0.000173	0.00175	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—LDHB—kidney cancer	0.000172	0.00173	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—RPL14—kidney cancer	0.000167	0.00169	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CCBL1—kidney cancer	0.000166	0.00168	CbGpPWpGaD
Chenodeoxycholic acid—Fatigue—Gemcitabine—kidney cancer	0.000164	0.000349	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Vincristine—kidney cancer	0.000164	0.000349	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Sorafenib—kidney cancer	0.000163	0.000347	CcSEcCtD
Chenodeoxycholic acid—Constipation—Gemcitabine—kidney cancer	0.000163	0.000346	CcSEcCtD
Chenodeoxycholic acid—Pain—Gemcitabine—kidney cancer	0.000163	0.000346	CcSEcCtD
Chenodeoxycholic acid—Nausea—Erlotinib—kidney cancer	0.000163	0.000346	CcSEcCtD
Chenodeoxycholic acid—Alopecia—Capecitabine—kidney cancer	0.000163	0.000346	CcSEcCtD
Chenodeoxycholic acid—Dry mouth—Paclitaxel—kidney cancer	0.000162	0.000346	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Sunitinib—kidney cancer	0.000162	0.000345	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—ITPR2—kidney cancer	0.000161	0.00162	CbGpPWpGaD
Chenodeoxycholic acid—Asthenia—Dactinomycin—kidney cancer	0.000161	0.000343	CcSEcCtD
Chenodeoxycholic acid—Confusional state—Paclitaxel—kidney cancer	0.000161	0.000342	CcSEcCtD
Chenodeoxycholic acid—Blood creatinine increased—Doxorubicin—kidney cancer	0.000161	0.000342	CcSEcCtD
Chenodeoxycholic acid—Malnutrition—Capecitabine—kidney cancer	0.00016	0.000341	CcSEcCtD
Chenodeoxycholic acid—Dehydration—Doxorubicin—kidney cancer	0.000159	0.000339	CcSEcCtD
Chenodeoxycholic acid—Oedema—Paclitaxel—kidney cancer	0.000159	0.000339	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.000159	0.0016	CbGpPWpGaD
Chenodeoxycholic acid—Abdominal pain—Vincristine—kidney cancer	0.000159	0.000337	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Vincristine—kidney cancer	0.000159	0.000337	CcSEcCtD
Chenodeoxycholic acid—Liver function test abnormal—Doxorubicin—kidney cancer	0.000158	0.000337	CcSEcCtD
Chenodeoxycholic acid—Infection—Paclitaxel—kidney cancer	0.000158	0.000337	CcSEcCtD
Chenodeoxycholic acid—Flatulence—Capecitabine—kidney cancer	0.000158	0.000336	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Sunitinib—kidney cancer	0.000157	0.000334	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Gemcitabine—kidney cancer	0.000157	0.000333	CcSEcCtD
Chenodeoxycholic acid—Shock—Paclitaxel—kidney cancer	0.000157	0.000333	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Sorafenib—kidney cancer	0.000157	0.000333	CcSEcCtD
Chenodeoxycholic acid—Orthostatic hypotension—Doxorubicin—kidney cancer	0.000157	0.000333	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain upper—Doxorubicin—kidney cancer	0.000157	0.000333	CcSEcCtD
Chenodeoxycholic acid—Nervous system disorder—Paclitaxel—kidney cancer	0.000156	0.000332	CcSEcCtD
Chenodeoxycholic acid—Thrombocytopenia—Paclitaxel—kidney cancer	0.000156	0.000332	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Tryptophan metabolism—CYP1A1—kidney cancer	0.000156	0.00157	CbGpPWpGaD
Chenodeoxycholic acid—Tachycardia—Paclitaxel—kidney cancer	0.000155	0.000331	CcSEcCtD
Chenodeoxycholic acid—Rash—Sorafenib—kidney cancer	0.000155	0.00033	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Sorafenib—kidney cancer	0.000155	0.00033	CcSEcCtD
Chenodeoxycholic acid—Back pain—Capecitabine—kidney cancer	0.000155	0.00033	CcSEcCtD
Chenodeoxycholic acid—Breast disorder—Doxorubicin—kidney cancer	0.000155	0.00033	CcSEcCtD
Chenodeoxycholic acid—Skin disorder—Paclitaxel—kidney cancer	0.000155	0.000329	CcSEcCtD
Chenodeoxycholic acid—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.000154	0.000328	CcSEcCtD
Chenodeoxycholic acid—Headache—Sorafenib—kidney cancer	0.000154	0.000328	CcSEcCtD
Chenodeoxycholic acid—Muscle spasms—Capecitabine—kidney cancer	0.000154	0.000328	CcSEcCtD
Chenodeoxycholic acid—Hyperhidrosis—Paclitaxel—kidney cancer	0.000154	0.000328	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Dactinomycin—kidney cancer	0.000154	0.000327	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—ALDH1A1—kidney cancer	0.000153	0.00154	CbGpPWpGaD
Chenodeoxycholic acid—Anorexia—Paclitaxel—kidney cancer	0.000152	0.000323	CcSEcCtD
Chenodeoxycholic acid—Gastritis—Doxorubicin—kidney cancer	0.000152	0.000323	CcSEcCtD
Chenodeoxycholic acid—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.000151	0.000322	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Sunitinib—kidney cancer	0.000151	0.000321	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.00015	0.00152	CbGpPWpGaD
Chenodeoxycholic acid—Body temperature increased—Gemcitabine—kidney cancer	0.00015	0.00032	CcSEcCtD
Chenodeoxycholic acid—Rash—Sunitinib—kidney cancer	0.000149	0.000318	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Sunitinib—kidney cancer	0.000149	0.000318	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—CA9—kidney cancer	0.000149	0.0015	CbGpPWpGaD
Chenodeoxycholic acid—Hypotension—Paclitaxel—kidney cancer	0.000149	0.000317	CcSEcCtD
Chenodeoxycholic acid—Ill-defined disorder—Capecitabine—kidney cancer	0.000149	0.000316	CcSEcCtD
Chenodeoxycholic acid—Headache—Sunitinib—kidney cancer	0.000149	0.000316	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	0.000149	0.0015	CbGpPWpGaD
Chenodeoxycholic acid—Asthma—Doxorubicin—kidney cancer	0.000148	0.000315	CcSEcCtD
Chenodeoxycholic acid—Dysphagia—Doxorubicin—kidney cancer	0.000148	0.000315	CcSEcCtD
Chenodeoxycholic acid—Influenza—Doxorubicin—kidney cancer	0.000148	0.000315	CcSEcCtD
Chenodeoxycholic acid—Anaemia—Capecitabine—kidney cancer	0.000148	0.000315	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Vincristine—kidney cancer	0.000148	0.000314	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—ACHE—kidney cancer	0.000147	0.00148	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—GSTT1—kidney cancer	0.000147	0.00148	CbGpPWpGaD
Chenodeoxycholic acid—Nausea—Sorafenib—kidney cancer	0.000146	0.000311	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	0.000146	0.00147	CbGpPWpGaD
Chenodeoxycholic acid—Pancreatitis—Doxorubicin—kidney cancer	0.000145	0.000309	CcSEcCtD
Chenodeoxycholic acid—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000145	0.000309	CcSEcCtD
Chenodeoxycholic acid—Malaise—Capecitabine—kidney cancer	0.000144	0.000307	CcSEcCtD
Chenodeoxycholic acid—Angina pectoris—Doxorubicin—kidney cancer	0.000144	0.000307	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—GLIPR1—kidney cancer	0.000144	0.00145	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PPAT—kidney cancer	0.000144	0.00145	CbGpPWpGaD
Chenodeoxycholic acid—Insomnia—Paclitaxel—kidney cancer	0.000144	0.000306	CcSEcCtD
Chenodeoxycholic acid—Vertigo—Capecitabine—kidney cancer	0.000144	0.000306	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Vincristine—kidney cancer	0.000144	0.000306	CcSEcCtD
Chenodeoxycholic acid—Syncope—Capecitabine—kidney cancer	0.000144	0.000306	CcSEcCtD
Chenodeoxycholic acid—Leukopenia—Capecitabine—kidney cancer	0.000143	0.000305	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Paclitaxel—kidney cancer	0.000143	0.000304	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Dactinomycin—kidney cancer	0.000143	0.000304	CcSEcCtD
Chenodeoxycholic acid—Bronchitis—Doxorubicin—kidney cancer	0.000142	0.000303	CcSEcCtD
Chenodeoxycholic acid—Dyspnoea—Paclitaxel—kidney cancer	0.000142	0.000302	CcSEcCtD
Chenodeoxycholic acid—Somnolence—Paclitaxel—kidney cancer	0.000142	0.000301	CcSEcCtD
Chenodeoxycholic acid—Palpitations—Capecitabine—kidney cancer	0.000142	0.000301	CcSEcCtD
Chenodeoxycholic acid—Rash—Dactinomycin—kidney cancer	0.000141	0.000301	CcSEcCtD
Chenodeoxycholic acid—Nausea—Sunitinib—kidney cancer	0.000141	0.0003	CcSEcCtD
Chenodeoxycholic acid—Loss of consciousness—Capecitabine—kidney cancer	0.000141	0.000299	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Paclitaxel—kidney cancer	0.00014	0.000298	CcSEcCtD
Chenodeoxycholic acid—Cough—Capecitabine—kidney cancer	0.00014	0.000297	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—SCARB1—kidney cancer	0.000139	0.0014	CbGpPWpGaD
Chenodeoxycholic acid—Dysuria—Doxorubicin—kidney cancer	0.000139	0.000295	CcSEcCtD
Chenodeoxycholic acid—Decreased appetite—Paclitaxel—kidney cancer	0.000138	0.000295	CcSEcCtD
Chenodeoxycholic acid—Hypertension—Capecitabine—kidney cancer	0.000138	0.000294	CcSEcCtD
Chenodeoxycholic acid—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000138	0.000293	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—PTGS1—kidney cancer	0.000138	0.00139	CbGpPWpGaD
Chenodeoxycholic acid—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000137	0.000293	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Paclitaxel—kidney cancer	0.000137	0.000292	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Vincristine—kidney cancer	0.000137	0.000292	CcSEcCtD
Chenodeoxycholic acid—Pollakiuria—Doxorubicin—kidney cancer	0.000137	0.000291	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Gemcitabine—kidney cancer	0.000136	0.00029	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Gene Expression—EIF4EBP1—kidney cancer	0.000136	0.00138	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—HSPB1—kidney cancer	0.000136	0.00138	CbGpPWpGaD
Chenodeoxycholic acid—Arthralgia—Capecitabine—kidney cancer	0.000136	0.00029	CcSEcCtD
Chenodeoxycholic acid—Myalgia—Capecitabine—kidney cancer	0.000136	0.00029	CcSEcCtD
Chenodeoxycholic acid—Chest pain—Capecitabine—kidney cancer	0.000136	0.00029	CcSEcCtD
Chenodeoxycholic acid—Pain—Paclitaxel—kidney cancer	0.000136	0.00029	CcSEcCtD
Chenodeoxycholic acid—Constipation—Paclitaxel—kidney cancer	0.000136	0.00029	CcSEcCtD
Chenodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000135	0.000288	CcSEcCtD
Chenodeoxycholic acid—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000135	0.000288	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—PSMD7—kidney cancer	0.000135	0.00136	CbGpPWpGaD
Chenodeoxycholic acid—Weight increased—Doxorubicin—kidney cancer	0.000135	0.000287	CcSEcCtD
Chenodeoxycholic acid—Discomfort—Capecitabine—kidney cancer	0.000135	0.000287	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Gemcitabine—kidney cancer	0.000135	0.000286	CcSEcCtD
Chenodeoxycholic acid—Weight decreased—Doxorubicin—kidney cancer	0.000134	0.000285	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—FH—kidney cancer	0.000134	0.00135	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—APRT—kidney cancer	0.000134	0.00135	CbGpPWpGaD
Chenodeoxycholic acid—Dry mouth—Capecitabine—kidney cancer	0.000133	0.000284	CcSEcCtD
Chenodeoxycholic acid—Nausea—Dactinomycin—kidney cancer	0.000133	0.000284	CcSEcCtD
Chenodeoxycholic acid—Pneumonia—Doxorubicin—kidney cancer	0.000133	0.000283	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Vincristine—kidney cancer	0.000133	0.000282	CcSEcCtD
Chenodeoxycholic acid—Infestation—Doxorubicin—kidney cancer	0.000132	0.000281	CcSEcCtD
Chenodeoxycholic acid—Infestation NOS—Doxorubicin—kidney cancer	0.000132	0.000281	CcSEcCtD
Chenodeoxycholic acid—Confusional state—Capecitabine—kidney cancer	0.000132	0.00028	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Paclitaxel—kidney cancer	0.000131	0.000279	CcSEcCtD
Chenodeoxycholic acid—Oedema—Capecitabine—kidney cancer	0.000131	0.000278	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Paclitaxel—kidney cancer	0.00013	0.000277	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Gemcitabine—kidney cancer	0.00013	0.000277	CcSEcCtD
Chenodeoxycholic acid—Renal failure—Doxorubicin—kidney cancer	0.00013	0.000276	CcSEcCtD
Chenodeoxycholic acid—Infection—Capecitabine—kidney cancer	0.00013	0.000276	CcSEcCtD
Chenodeoxycholic acid—Jaundice—Doxorubicin—kidney cancer	0.000129	0.000274	CcSEcCtD
Chenodeoxycholic acid—Shock—Capecitabine—kidney cancer	0.000129	0.000274	CcSEcCtD
Chenodeoxycholic acid—Conjunctivitis—Doxorubicin—kidney cancer	0.000128	0.000273	CcSEcCtD
Chenodeoxycholic acid—Urinary tract infection—Doxorubicin—kidney cancer	0.000128	0.000273	CcSEcCtD
Chenodeoxycholic acid—Nervous system disorder—Capecitabine—kidney cancer	0.000128	0.000273	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—BCHE—kidney cancer	0.000128	0.00129	CbGpPWpGaD
Chenodeoxycholic acid—Thrombocytopenia—Capecitabine—kidney cancer	0.000128	0.000272	CcSEcCtD
Chenodeoxycholic acid—Tachycardia—Capecitabine—kidney cancer	0.000128	0.000271	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Vincristine—kidney cancer	0.000127	0.000271	CcSEcCtD
Chenodeoxycholic acid—Skin disorder—Capecitabine—kidney cancer	0.000127	0.00027	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Gene Expression—PSMD7—kidney cancer	0.000127	0.00128	CbGpPWpGaD
Chenodeoxycholic acid—Sweating—Doxorubicin—kidney cancer	0.000127	0.000269	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—CRABP1—kidney cancer	0.000127	0.00128	CbGpPWpGaD
Chenodeoxycholic acid—Urticaria—Paclitaxel—kidney cancer	0.000127	0.000269	CcSEcCtD
Chenodeoxycholic acid—Rash—Vincristine—kidney cancer	0.000126	0.000269	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—SLC5A5—kidney cancer	0.000126	0.00127	CbGpPWpGaD
Chenodeoxycholic acid—Hyperhidrosis—Capecitabine—kidney cancer	0.000126	0.000269	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Vincristine—kidney cancer	0.000126	0.000269	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.000126	0.00127	CbGpPWpGaD
Chenodeoxycholic acid—Haematuria—Doxorubicin—kidney cancer	0.000126	0.000268	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—GPC3—kidney cancer	0.000126	0.00127	CbGpPWpGaD
Chenodeoxycholic acid—Abdominal pain—Paclitaxel—kidney cancer	0.000126	0.000268	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Paclitaxel—kidney cancer	0.000126	0.000268	CcSEcCtD
Chenodeoxycholic acid—Headache—Vincristine—kidney cancer	0.000126	0.000267	CcSEcCtD
Chenodeoxycholic acid—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000125	0.000266	CcSEcCtD
Chenodeoxycholic acid—Epistaxis—Doxorubicin—kidney cancer	0.000125	0.000265	CcSEcCtD
Chenodeoxycholic acid—Anorexia—Capecitabine—kidney cancer	0.000125	0.000265	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.000124	0.00125	CbGpPWpGaD
Chenodeoxycholic acid—Sinusitis—Doxorubicin—kidney cancer	0.000124	0.000264	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—CA2—kidney cancer	0.000122	0.00123	CbGpPWpGaD
Chenodeoxycholic acid—Hypotension—Capecitabine—kidney cancer	0.000122	0.00026	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—SLC2A1—kidney cancer	0.000122	0.00123	CbGpPWpGaD
Chenodeoxycholic acid—Vomiting—Gemcitabine—kidney cancer	0.000121	0.000257	CcSEcCtD
Chenodeoxycholic acid—Rash—Gemcitabine—kidney cancer	0.00012	0.000255	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Gemcitabine—kidney cancer	0.00012	0.000255	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—ALAD—kidney cancer	0.000119	0.0012	CbGpPWpGaD
Chenodeoxycholic acid—Haemoglobin—Doxorubicin—kidney cancer	0.000119	0.000254	CcSEcCtD
Chenodeoxycholic acid—Headache—Gemcitabine—kidney cancer	0.000119	0.000254	CcSEcCtD
Chenodeoxycholic acid—Nausea—Vincristine—kidney cancer	0.000119	0.000253	CcSEcCtD
Chenodeoxycholic acid—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000119	0.000253	CcSEcCtD
Chenodeoxycholic acid—Rhinitis—Doxorubicin—kidney cancer	0.000119	0.000253	CcSEcCtD
Chenodeoxycholic acid—Haemorrhage—Doxorubicin—kidney cancer	0.000119	0.000252	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	0.000118	0.00119	CbGpPWpGaD
Chenodeoxycholic acid—Insomnia—Capecitabine—kidney cancer	0.000118	0.000251	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—ITPR2—kidney cancer	0.000118	0.00119	CbGpPWpGaD
Chenodeoxycholic acid—Pharyngitis—Doxorubicin—kidney cancer	0.000118	0.00025	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Capecitabine—kidney cancer	0.000117	0.00025	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Paclitaxel—kidney cancer	0.000117	0.00025	CcSEcCtD
Chenodeoxycholic acid—Urinary tract disorder—Doxorubicin—kidney cancer	0.000117	0.000249	CcSEcCtD
Chenodeoxycholic acid—Oedema peripheral—Doxorubicin—kidney cancer	0.000117	0.000249	CcSEcCtD
Chenodeoxycholic acid—Connective tissue disorder—Doxorubicin—kidney cancer	0.000117	0.000248	CcSEcCtD
Chenodeoxycholic acid—Dyspnoea—Capecitabine—kidney cancer	0.000117	0.000248	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—ST3GAL2—kidney cancer	0.000116	0.00117	CbGpPWpGaD
Chenodeoxycholic acid—Urethral disorder—Doxorubicin—kidney cancer	0.000116	0.000247	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Capecitabine—kidney cancer	0.000115	0.000245	CcSEcCtD
Chenodeoxycholic acid—Visual impairment—Doxorubicin—kidney cancer	0.000114	0.000243	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Paclitaxel—kidney cancer	0.000114	0.000243	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Gene Expression—JUNB—kidney cancer	0.000114	0.00115	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—ALDH1A1—kidney cancer	0.000114	0.00115	CbGpPWpGaD
Chenodeoxycholic acid—Decreased appetite—Capecitabine—kidney cancer	0.000114	0.000242	CcSEcCtD
Chenodeoxycholic acid—Nausea—Gemcitabine—kidney cancer	0.000113	0.00024	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000113	0.00024	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Capecitabine—kidney cancer	0.000113	0.00024	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Paclitaxel—kidney cancer	0.000113	0.00024	CcSEcCtD
Chenodeoxycholic acid—Pain—Capecitabine—kidney cancer	0.000112	0.000238	CcSEcCtD
Chenodeoxycholic acid—Constipation—Capecitabine—kidney cancer	0.000112	0.000238	CcSEcCtD
Chenodeoxycholic acid—Eye disorder—Doxorubicin—kidney cancer	0.000111	0.000236	CcSEcCtD
Chenodeoxycholic acid—Tinnitus—Doxorubicin—kidney cancer	0.000111	0.000235	CcSEcCtD
Chenodeoxycholic acid—Cardiac disorder—Doxorubicin—kidney cancer	0.00011	0.000234	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—SLC5A3—kidney cancer	0.000109	0.0011	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PGK1—kidney cancer	0.000109	0.0011	CbGpPWpGaD
Chenodeoxycholic acid—Diarrhoea—Paclitaxel—kidney cancer	0.000109	0.000232	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—POMC—kidney cancer	0.000109	0.00109	CbGpPWpGaD
Chenodeoxycholic acid—Feeling abnormal—Capecitabine—kidney cancer	0.000108	0.000229	CcSEcCtD
Chenodeoxycholic acid—Angiopathy—Doxorubicin—kidney cancer	0.000108	0.000229	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—GSTT1—kidney cancer	0.000107	0.00108	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—ACHE—kidney cancer	0.000107	0.00108	CbGpPWpGaD
Chenodeoxycholic acid—Immune system disorder—Doxorubicin—kidney cancer	0.000107	0.000228	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—LDHB—kidney cancer	0.000107	0.00108	CbGpPWpGaD
Chenodeoxycholic acid—Gastrointestinal pain—Capecitabine—kidney cancer	0.000107	0.000227	CcSEcCtD
Chenodeoxycholic acid—Mediastinal disorder—Doxorubicin—kidney cancer	0.000107	0.000227	CcSEcCtD
Chenodeoxycholic acid—Chills—Doxorubicin—kidney cancer	0.000106	0.000226	CcSEcCtD
Chenodeoxycholic acid—Arrhythmia—Doxorubicin—kidney cancer	0.000106	0.000225	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Paclitaxel—kidney cancer	0.000105	0.000224	CcSEcCtD
Chenodeoxycholic acid—Alopecia—Doxorubicin—kidney cancer	0.000105	0.000223	CcSEcCtD
Chenodeoxycholic acid—Urticaria—Capecitabine—kidney cancer	0.000104	0.000221	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Capecitabine—kidney cancer	0.000103	0.00022	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Capecitabine—kidney cancer	0.000103	0.00022	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	0.000103	0.00104	CbGpPWpGaD
Chenodeoxycholic acid—Malnutrition—Doxorubicin—kidney cancer	0.000103	0.00022	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.000102	0.00103	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—GSTP1—kidney cancer	0.000102	0.00103	CbGpPWpGaD
Chenodeoxycholic acid—Flatulence—Doxorubicin—kidney cancer	0.000102	0.000216	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—SCARB1—kidney cancer	0.000102	0.00102	CbGpPWpGaD
Chenodeoxycholic acid—Tension—Doxorubicin—kidney cancer	0.000101	0.000216	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Paclitaxel—kidney cancer	0.000101	0.000215	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—PTGS1—kidney cancer	0.000101	0.00101	CbGpPWpGaD
Chenodeoxycholic acid—Rash—Paclitaxel—kidney cancer	0.0001	0.000214	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Paclitaxel—kidney cancer	0.0001	0.000213	CcSEcCtD
Chenodeoxycholic acid—Nervousness—Doxorubicin—kidney cancer	0.0001	0.000213	CcSEcCtD
Chenodeoxycholic acid—Back pain—Doxorubicin—kidney cancer	9.98e-05	0.000212	CcSEcCtD
Chenodeoxycholic acid—Headache—Paclitaxel—kidney cancer	9.98e-05	0.000212	CcSEcCtD
Chenodeoxycholic acid—Muscle spasms—Doxorubicin—kidney cancer	9.92e-05	0.000211	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—PSMD7—kidney cancer	9.87e-05	0.000995	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—ABCB1—kidney cancer	9.64e-05	0.000972	CbGpPWpGaD
Chenodeoxycholic acid—Hypersensitivity—Capecitabine—kidney cancer	9.63e-05	0.000205	CcSEcCtD
Chenodeoxycholic acid—Ill-defined disorder—Doxorubicin—kidney cancer	9.58e-05	0.000204	CcSEcCtD
Chenodeoxycholic acid—Anaemia—Doxorubicin—kidney cancer	9.54e-05	0.000203	CcSEcCtD
Chenodeoxycholic acid—Nausea—Paclitaxel—kidney cancer	9.46e-05	0.000201	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	9.39e-05	0.000947	CbGpPWpGaD
Chenodeoxycholic acid—Asthenia—Capecitabine—kidney cancer	9.38e-05	0.0002	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—GSTM1—kidney cancer	9.36e-05	0.000944	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—BCHE—kidney cancer	9.35e-05	0.000943	CbGpPWpGaD
Chenodeoxycholic acid—Malaise—Doxorubicin—kidney cancer	9.31e-05	0.000198	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—CA9—kidney cancer	9.28e-05	0.000936	CbGpPWpGaD
Chenodeoxycholic acid—Vertigo—Doxorubicin—kidney cancer	9.27e-05	0.000197	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Gene Expression—CDKN2B—kidney cancer	9.27e-05	0.000935	CbGpPWpGaD
Chenodeoxycholic acid—Syncope—Doxorubicin—kidney cancer	9.26e-05	0.000197	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Capecitabine—kidney cancer	9.25e-05	0.000197	CcSEcCtD
Chenodeoxycholic acid—Leukopenia—Doxorubicin—kidney cancer	9.24e-05	0.000197	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—SLC5A5—kidney cancer	9.24e-05	0.000931	CbGpPWpGaD
Chenodeoxycholic acid—Palpitations—Doxorubicin—kidney cancer	9.12e-05	0.000194	CcSEcCtD
Chenodeoxycholic acid—Loss of consciousness—Doxorubicin—kidney cancer	9.07e-05	0.000193	CcSEcCtD
Chenodeoxycholic acid—Cough—Doxorubicin—kidney cancer	9.01e-05	0.000192	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—GSTT1—kidney cancer	8.99e-05	0.000906	CbGpPWpGaD
Chenodeoxycholic acid—Convulsion—Doxorubicin—kidney cancer	8.94e-05	0.00019	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Capecitabine—kidney cancer	8.94e-05	0.00019	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—SLC2A1—kidney cancer	8.92e-05	0.0009	CbGpPWpGaD
Chenodeoxycholic acid—Hypertension—Doxorubicin—kidney cancer	8.91e-05	0.00019	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—CYP1A1—kidney cancer	8.87e-05	0.000894	CbGpPWpGaD
Chenodeoxycholic acid—Arthralgia—Doxorubicin—kidney cancer	8.79e-05	0.000187	CcSEcCtD
Chenodeoxycholic acid—Chest pain—Doxorubicin—kidney cancer	8.79e-05	0.000187	CcSEcCtD
Chenodeoxycholic acid—Myalgia—Doxorubicin—kidney cancer	8.79e-05	0.000187	CcSEcCtD
Chenodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	8.73e-05	0.000186	CcSEcCtD
Chenodeoxycholic acid—Discomfort—Doxorubicin—kidney cancer	8.68e-05	0.000185	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	8.66e-05	0.000873	CbGpPWpGaD
Chenodeoxycholic acid—Dizziness—Capecitabine—kidney cancer	8.64e-05	0.000184	CcSEcCtD
Chenodeoxycholic acid—Dry mouth—Doxorubicin—kidney cancer	8.59e-05	0.000183	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—RAF1—kidney cancer	8.51e-05	0.000858	CbGpPWpGaD
Chenodeoxycholic acid—Confusional state—Doxorubicin—kidney cancer	8.49e-05	0.000181	CcSEcCtD
Chenodeoxycholic acid—Oedema—Doxorubicin—kidney cancer	8.42e-05	0.000179	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—PTGS1—kidney cancer	8.42e-05	0.000849	CbGpPWpGaD
Chenodeoxycholic acid—Infection—Doxorubicin—kidney cancer	8.37e-05	0.000178	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Capecitabine—kidney cancer	8.31e-05	0.000177	CcSEcCtD
Chenodeoxycholic acid—Shock—Doxorubicin—kidney cancer	8.29e-05	0.000176	CcSEcCtD
Chenodeoxycholic acid—Nervous system disorder—Doxorubicin—kidney cancer	8.26e-05	0.000176	CcSEcCtD
Chenodeoxycholic acid—Thrombocytopenia—Doxorubicin—kidney cancer	8.25e-05	0.000175	CcSEcCtD
Chenodeoxycholic acid—Rash—Capecitabine—kidney cancer	8.24e-05	0.000175	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Capecitabine—kidney cancer	8.23e-05	0.000175	CcSEcCtD
Chenodeoxycholic acid—Tachycardia—Doxorubicin—kidney cancer	8.22e-05	0.000175	CcSEcCtD
Chenodeoxycholic acid—Headache—Capecitabine—kidney cancer	8.19e-05	0.000174	CcSEcCtD
Chenodeoxycholic acid—Skin disorder—Doxorubicin—kidney cancer	8.18e-05	0.000174	CcSEcCtD
Chenodeoxycholic acid—Hyperhidrosis—Doxorubicin—kidney cancer	8.14e-05	0.000173	CcSEcCtD
Chenodeoxycholic acid—Anorexia—Doxorubicin—kidney cancer	8.03e-05	0.000171	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—CRABP1—kidney cancer	7.89e-05	0.000796	CbGpPWpGaD
Chenodeoxycholic acid—Hypotension—Doxorubicin—kidney cancer	7.87e-05	0.000167	CcSEcCtD
Chenodeoxycholic acid—Nausea—Capecitabine—kidney cancer	7.76e-05	0.000165	CcSEcCtD
Chenodeoxycholic acid—Musculoskeletal discomfort—Doxorubicin—kidney cancer	7.68e-05	0.000163	CcSEcCtD
Chenodeoxycholic acid—Insomnia—Doxorubicin—kidney cancer	7.62e-05	0.000162	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	7.62e-05	0.000768	CbGpPWpGaD
Chenodeoxycholic acid—Paraesthesia—Doxorubicin—kidney cancer	7.56e-05	0.000161	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	7.55e-05	0.000761	CbGpPWpGaD
Chenodeoxycholic acid—Dyspnoea—Doxorubicin—kidney cancer	7.51e-05	0.00016	CcSEcCtD
Chenodeoxycholic acid—Somnolence—Doxorubicin—kidney cancer	7.49e-05	0.000159	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—MYC—kidney cancer	7.46e-05	0.000753	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—GSTP1—kidney cancer	7.44e-05	0.00075	CbGpPWpGaD
Chenodeoxycholic acid—Dyspepsia—Doxorubicin—kidney cancer	7.42e-05	0.000158	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—ITPR2—kidney cancer	7.34e-05	0.00074	CbGpPWpGaD
Chenodeoxycholic acid—Decreased appetite—Doxorubicin—kidney cancer	7.32e-05	0.000156	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.29e-05	0.000735	CbGpPWpGaD
Chenodeoxycholic acid—Gastrointestinal disorder—Doxorubicin—kidney cancer	7.27e-05	0.000155	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Doxorubicin—kidney cancer	7.26e-05	0.000155	CcSEcCtD
Chenodeoxycholic acid—Constipation—Doxorubicin—kidney cancer	7.2e-05	0.000153	CcSEcCtD
Chenodeoxycholic acid—Pain—Doxorubicin—kidney cancer	7.2e-05	0.000153	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—ABCB1—kidney cancer	7.04e-05	0.00071	CbGpPWpGaD
Chenodeoxycholic acid—Feeling abnormal—Doxorubicin—kidney cancer	6.94e-05	0.000148	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Doxorubicin—kidney cancer	6.89e-05	0.000147	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—GSTM1—kidney cancer	6.84e-05	0.00069	CbGpPWpGaD
Chenodeoxycholic acid—Urticaria—Doxorubicin—kidney cancer	6.69e-05	0.000142	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—GSTT1—kidney cancer	6.69e-05	0.000675	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—ACHE—kidney cancer	6.69e-05	0.000675	CbGpPWpGaD
Chenodeoxycholic acid—Body temperature increased—Doxorubicin—kidney cancer	6.66e-05	0.000142	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Doxorubicin—kidney cancer	6.66e-05	0.000142	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—POMC—kidney cancer	6.61e-05	0.000667	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—CYP1A1—kidney cancer	6.48e-05	0.000654	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—SCARB1—kidney cancer	6.33e-05	0.000639	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PTGS1—kidney cancer	6.27e-05	0.000632	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—GSTP1—kidney cancer	6.23e-05	0.000628	CbGpPWpGaD
Chenodeoxycholic acid—Hypersensitivity—Doxorubicin—kidney cancer	6.21e-05	0.000132	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—PSMD7—kidney cancer	6.15e-05	0.00062	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	6.14e-05	0.000619	CbGpPWpGaD
Chenodeoxycholic acid—Asthenia—Doxorubicin—kidney cancer	6.04e-05	0.000129	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Doxorubicin—kidney cancer	5.96e-05	0.000127	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—BCHE—kidney cancer	5.83e-05	0.000588	CbGpPWpGaD
Chenodeoxycholic acid—Diarrhoea—Doxorubicin—kidney cancer	5.76e-05	0.000123	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—SLC5A5—kidney cancer	5.76e-05	0.000581	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—GSTM1—kidney cancer	5.72e-05	0.000577	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	5.64e-05	0.000569	CbGpPWpGaD
Chenodeoxycholic acid—Dizziness—Doxorubicin—kidney cancer	5.57e-05	0.000119	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—SLC2A1—kidney cancer	5.56e-05	0.000561	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	5.43e-05	0.000547	CbGpPWpGaD
Chenodeoxycholic acid—Vomiting—Doxorubicin—kidney cancer	5.36e-05	0.000114	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	5.35e-05	0.00054	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.33e-05	0.000537	CbGpPWpGaD
Chenodeoxycholic acid—Rash—Doxorubicin—kidney cancer	5.31e-05	0.000113	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Doxorubicin—kidney cancer	5.31e-05	0.000113	CcSEcCtD
Chenodeoxycholic acid—Headache—Doxorubicin—kidney cancer	5.28e-05	0.000112	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—PTGS2—kidney cancer	5.28e-05	0.000532	CbGpPWpGaD
Chenodeoxycholic acid—Nausea—Doxorubicin—kidney cancer	5e-05	0.000106	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—POMC—kidney cancer	4.83e-05	0.000487	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ACY1—kidney cancer	4.77e-05	0.000481	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—GSTP1—kidney cancer	4.64e-05	0.000468	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PTEN—kidney cancer	4.6e-05	0.000464	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—ABCB1—kidney cancer	4.39e-05	0.000443	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—GSTM1—kidney cancer	4.26e-05	0.00043	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PDHB—kidney cancer	4.06e-05	0.000409	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—POMC—kidney cancer	4.05e-05	0.000408	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CYP1A1—kidney cancer	4.04e-05	0.000407	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PTGS2—kidney cancer	3.85e-05	0.000389	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CCBL1—kidney cancer	3.82e-05	0.000385	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—MAPK3—kidney cancer	3.69e-05	0.000373	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—MYC—kidney cancer	3.59e-05	0.000362	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PTEN—kidney cancer	3.36e-05	0.000339	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GLIPR1—kidney cancer	3.31e-05	0.000334	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PPAT—kidney cancer	3.31e-05	0.000334	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PIK3CA—kidney cancer	3.25e-05	0.000327	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—FH—kidney cancer	3.08e-05	0.00031	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—APRT—kidney cancer	3.08e-05	0.00031	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—POMC—kidney cancer	3.01e-05	0.000304	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GPC3—kidney cancer	2.89e-05	0.000292	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CA2—kidney cancer	2.81e-05	0.000284	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ALAD—kidney cancer	2.74e-05	0.000276	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ST3GAL2—kidney cancer	2.68e-05	0.00027	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ALDH1A1—kidney cancer	2.61e-05	0.000264	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PGK1—kidney cancer	2.51e-05	0.000253	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—SLC5A3—kidney cancer	2.51e-05	0.000253	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—LDHB—kidney cancer	2.46e-05	0.000248	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PTGS2—kidney cancer	2.4e-05	0.000242	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PIK3CA—kidney cancer	2.37e-05	0.000239	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CA9—kidney cancer	2.13e-05	0.000215	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PTEN—kidney cancer	2.1e-05	0.000211	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CRABP1—kidney cancer	1.81e-05	0.000183	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ITPR2—kidney cancer	1.69e-05	0.00017	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ACHE—kidney cancer	1.54e-05	0.000155	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GSTT1—kidney cancer	1.54e-05	0.000155	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PIK3CA—kidney cancer	1.48e-05	0.000149	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—SCARB1—kidney cancer	1.45e-05	0.000147	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PTGS1—kidney cancer	1.44e-05	0.000145	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PSMD7—kidney cancer	1.41e-05	0.000142	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—BCHE—kidney cancer	1.34e-05	0.000135	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—SLC5A5—kidney cancer	1.32e-05	0.000133	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—SLC2A1—kidney cancer	1.28e-05	0.000129	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GSTP1—kidney cancer	1.07e-05	0.000107	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ABCB1—kidney cancer	1.01e-05	0.000102	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GSTM1—kidney cancer	9.79e-06	9.87e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CYP1A1—kidney cancer	9.28e-06	9.36e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—POMC—kidney cancer	6.92e-06	6.98e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PTGS2—kidney cancer	5.52e-06	5.56e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PTEN—kidney cancer	4.81e-06	4.85e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PIK3CA—kidney cancer	3.39e-06	3.42e-05	CbGpPWpGaD
